Cargando…
MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients
BACKGROUND: Multiple Endocrine Neoplasia type 1 (MEN1) is diagnosed when two out of the three primary MEN1-associated endocrine tumors occur in a patient. Up to 10–30 % of those patients have no mutation in the MEN1 gene. It is unclear if the phenotype and course of the disease of mutation-negative...
Autores principales: | de Laat, Joanne M., van der Luijt, Rob B., Pieterman, Carolina R. C., Oostveen, Maria P., Hermus, Ad R., Dekkers, Olaf M., de Herder, Wouter W., van der Horst-Schrivers, Anouk N., Drent, Madeleine L., Bisschop, Peter H., Havekes, Bas, Vriens, Menno R., Valk, Gerlof D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109674/ https://www.ncbi.nlm.nih.gov/pubmed/27842554 http://dx.doi.org/10.1186/s12916-016-0708-1 |
Ejemplares similares
-
Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG)
por: van Beek, Dirk‐Jan, et al.
Publicado: (2019) -
Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice
por: van Beek, Dirk-Jan, et al.
Publicado: (2022) -
‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1
por: van Beek, Dirk-Jan, et al.
Publicado: (2018) -
Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up
por: Twigt, Bas A, et al.
Publicado: (2013) -
Update on the clinical management of multiple endocrine neoplasia type 1
por: Pieterman, Carolina R. C., et al.
Publicado: (2022)